ADAR and COVID-19: As expected, the score was significantly higher in the COVID-19 group compared to the control group (Wilcoxson; COVID-19: 0.37 ± 0.5, controls: –0.32 ± 0.46, P-value = 1.5e-49) (Figure 3B) as ADAR1 expression levels were highly correlated with ISG38 score (Spearman; R = 0.85, P < 2.2e-16) (Figure 3C).